Opioid and neurokinin activities of substance P fragments and their analogs.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Pharmacology

• Publication date

  1991-02-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(91)90038-RPMID 1710992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord.

  1990cited by this paper
• Role of substance P amino terminal metabolites in substance P-induced desensitization in mice.

  1990cited by this paper
• Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes

  1990cited by this paper
• Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception

  1990cited by this paper
• Molecular characterization of a functional cDNA for rat substance P receptor.

  1989cited by this paper
• Is substance P a primary afferent neurotransmitter for nociceptive input? II. Spinalization does not reduce and intrathecal morphine potentiates behavioral responses to substance P.

  1988cited by this paper
• Is substance P a primary afferent neurotransmitter for nociceptive input? I. Analysis of pain-related behaviors resulting from intrathecal administration of substance P and 6 excitatory compounds.

  1988cited by this paper
• Is substance P a primary afferent neurotransmitter for nociceptive input? III. Valproic acid and chlordiazepoxide decrease behaviors elicited by intrathecal injection of substance P and excitatory compounds.

  1988cited by this paper
• Desensitization to intrathecal substance P in mice: possible involvement of opioids

  1988cited by this paper
• Pharmacological Studies of Grooming and Scratching Behavior Elicited by Spinal Substance P and Excitatory Amino Acids a

  1988cited by this paper
• Characterization of the effects produced by neurokinins and three agonists selective for neurokinin receptor subtypes in a spinal nociceptive reflex of the rat.

  1988cited by this paper
• Is substance P a primary afferent neurotransmitter for nociceptive input? IV. 2-Amino-5-phosphonovalerate (APV) and [D-Pro2,D-Trp7,9]-substance P exert different effects on behaviors induced by intrathecal substance P, strychnine and kainic acid.

  1988cited by this paper
• Species differences in the behavioral toxicity produced by intrathecal substance P antagonists: relationship to analgesia.

  1987cited by this paper
• cDNA eloping of bovine substance-K receptor through oocyte expression system

  1987cited by this paper
• Behavioural effects of receptor‐specific substance P agonists

  1987cited by this paper
• Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors.

  1987cited by this paper
• Capsaicin-induced inhibition of motility of the rat isolated vas deferens: do multiple neuropeptides mediate the visceromotor effects of capsaicin?

  1987cited by this paper
• Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse.

  1987cited by this paper
• Pharmacological receptors for substance P and neurokinins.

  1987cited by this paper
• Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice.

  1986cited by this paper
• Intradermal hypertonic saline-induced behavior as a nociceptive test in mice.

  1986cited by this paper
• Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system.

  1986cited by this paper
• Behavioural effects of tachykinins and related peptides.

  1986cited by this paper
• Multiple tachykinin binding sites in peripheral tissues and in brain.

  1986cited by this paper
• Neurokinin binding site nomenclature — definition

  1986cited by this paper
• Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system.

  1986cited by this paper
• A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in rat brain.

  1986cited by this paper
• Regional distribution of substance P, neurokinin α and neurokinin β in rat spinal cord, nerve roots and dorsal root ganglia, and the effects of dorsal root section or spinal transection

  1985cited by this paper
• Regional distribution of substance P, neurokinin alpha and neurokinin beta in rat spinal cord, nerve roots and dorsal root ganglia, and the effects of dorsal root section or spinal transection.

  1985cited by this paper
• Multiple tachykinin receptors

  1985cited by this paper
• Characterization of the hyperalgesic effect induced by intrathecal injection of substance P.

  1985cited by this paper
• Effects of iontophoretically released peptides on primate spinothalamic tract cells

  1984cited by this paper
• Slow excitatory transmission in rat dorsal horn: possible mediation by peptides.

  1984cited by this paper
• Manual of Pharmacologic Calculations: With Computer Programs

  1984cited by this paper
• Neuromedin K, a tool to further distinguish two central tachykinin binding sites.

  1984cited by this paper
• Differential localization of tachykinin receptors in rat spinal cord.

  1984cited by this paper
• Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level.

  1983cited by this paper
• Substance P.

  1983cited by this paper
• Substance P and behavior: opposite effects of N-terminal and C-terminal fragments.

  1983cited by this paper
• An approach to the self regulatory mechanism of substance P actions: II. Biological activity of new synthetic peptide analogs related both to enkephalin and substance P.

  1983cited by this paper
• A fragment of substance P with specific central activity: SP(1-7).

  1982cited by this paper
• Substance P reduces tail‐flick latency: Implications for chronic pain syndromes

  1982cited by this paper
• The possible existence of multiple receptors for substance P

  1982cited by this paper
• Behavioral evidence that substance P may be a spinal cord sensory neurotransmitter.

  1981cited by this paper
• Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice.

  1981cited by this paper
• Sensory and motor functions of spinal cord substance P.

  1981cited by this paper
• Contracting activity of C-terminal fragments and a C-terminal hexapeptide analogue of substance P on non-stimulated and electrically stimulated isolated guinea-pig ileum.

  1981cited by this paper
• Intrathecal substance P depresses the tail-flick response — Antagonism by naloxone

  1981cited by this paper
• Intrathecal morphine in mice: a new technique.

  1980cited by this paper
• Effects of intrathecal and intracerebroventricular injections of substance P on nociception in the rat and mouse [proceedings].

  1979cited by this paper
• Dual actions of substance P on nociception: possible role of endogenous opioids.

  1978cited by this paper
• Effects of substance P on functionally identified units in cat spinal cord.

  1976cited by this paper
• Biological activity of C-terminal partial sequences of substance P.

  1976cited by this paper

• Multitarget Ligands that Comprise Opioid/Nonopioid Pharmacophores for Pain Management: Current State of the Science.

  2024cites this paper
• Neurokinin‐1 receptor‐based bivalent drugs in pain management: The journey to nowhere?

  2019cites this paper
• Cardiorespiratory action of opioid/tachykinin agonist peptide hybrid in anaesthetized rats: Transduction pathways

  2017cites this paper
• Cardiorespiratory activity of C-terminal pentapeptide of substance P in anaesthetized rats.

  2016cites this paper
• Hybrid opioid/non-opioid ligands in pain research.

  2014cites this paper
• Chapter 216 – Opioid-Substance P Chimeric Peptides

  2013cites this paper
• Opioid-substance P chimeric peptides

  2010cites this paper
• Synthesis and pharmacological analysis of a morphine/substance P chimeric molecule with full analgesic potency in morphine-tolerant rats.

  2007cites this paper
• CHAPTER 191 – Opioid-Substance P Chimeric Peptides

  2006cites this paper
• New challenges in the study of the mammalian tachykinins.

  2005cites this paper
• Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration.

  2004cites this paper
• Hemokinins and endokinins

  2004cites this paper
• Advances in analgesic drug design and delivery: a current survey.

  2004cites this paper
• Inhibition of morphine tolerance development by a substance P-opioid peptide chimera.

  2000cites this paper
• Substance P and related peptides in porcine cortex: whole tissue and nuclear localization.

  1998cites this paper
• Alternative forms of interaction of substance P and opioids in nociceptive transmission

  1998cites this paper
• Substance P-associated increase of intra-articular temperature and pain threshold in the arthritic TMJ.

  1998cites this paper
• Neuropeptides in the immunomodulation: substance P-induced stimulation of immune response in mice.

  1997cites this paper
• The role of dopaminergic system in the immunostimulatory effects of substance P and its analog

  1997cites this paper
• Fragments of galanin message-associated peptide (GMAP) modulate the spinal flexor reflex in rat.

  1996cites this paper
• Vasorelaxation by casomokinin L, a derivative of beta-casomorphin and casoxin D, is mediated by NK1 receptor.

  1996cites this paper
• Synthesis and biological properties of gamma-glutamyl-dermorphin, a prodrug.

  1996cites this paper
• Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats.

  1995cites this paper
• Spinal co-administration of peptide substance P antagonist increases antinociceptive effect of the opioid peptide biphalin.

  1994cites this paper
• N-acetyl beta-endorphin-(1-31) and substance P regulate the supraspinal antinociception mediated by mu opioid and alpha-2 adrenoceptors but not by delta opioid receptors in the mouse.

  1993cites this paper
• Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins.

  1993cites this paper
• Phantom sensation, phantom pain, and stump pain.

  1993cites this paper